Innate Pharma S.A. at its annual general meeting held on May 20, 2022, announced that Dr. Sally Bennett was appointed as new member of the Supervisory Board. She was appointed as a member of the Audit Committee during the Supervisory Board Meeting of May 20, 2022. Dr. Sally Bennett has over 20 years of experience in financial analysis and capital markets in the life sciences and biopharmaceutical industry.

She is currently a senior member of the private investment team (part-time) at HealthCor. Patrick Langlois decided to resign from its mandate of Supervisory Board member of Innate Pharma.